Asthma — all decisions

The Board granted service connection for headaches and asthma, resolving reasonable doubt in the Veteran's favor.

The Board granted service connection for a cervical spine disability and bilateral hearing loss, while denying service connection for asthma, anxiety disorder, adjustment disorder, depressive disorder, GERD, migraines (also claimed as headaches), insomnia, left hip disability, right hip disability, and plantar fasciitis.

The appeal for service connection for PTSD with persistent depressive disorder and a thoracolumbar spine disability was dismissed due to a claims processing error, while the appeal for sinusitis was denied. The Veteran's initial rating for mild restrictive lung disease (RLD) was granted.

The claim for service connection for restrictive airway disease to include asthma was reopened based on new and relevant evidence, but the issue is remanded for further development.

The Board granted service connection for chronic sinusitis, allergic rhinitis, chronic bronchitis, and asthma, finding that these conditions are causally related to the Veteran's military service.

The appeal was dismissed as the Veteran did not file claims for major depression, intermittent explosive disorder, diabetes, tinnitus, and bilateral feet conditions. The Board also denied a higher rating and an earlier effective date for bronchial asthma.

The Board dismissed the claims for service connection for a psychiatric disorder, asthma, and sinusitis as they have been granted and rendered moot.

The Board denied service connection for a respiratory disorder, including asthma and COPD, finding no evidence of in-service incurrence or a causal relationship to service.

The Board denied the Veteran's claim for a rating in excess of 30 percent prior to September 9, 2023, for service-connected asthma and restrictive lung disease.

The Board granted service connection for gastrointestinal reflux disease (GERD), chronic kidney disease, unspecified asthma without complications, and chronic obstructive pulmonary disease on a direct basis.

The Board denied service connection for sleep apnea and a compensable rating for bronchitis, but granted service connection for asthma.

The Board denied the Veteran's appeal for separate disability ratings for obstructive sleep apnea and asthma, as these conditions are considered to be a single disability under VA regulations.

The Board denied a rating in excess of 10 percent for maxillary sinusitis and remanded the service connection claims for rhinitis, bronchitis, and asthma.

The Board granted the veteran's appeal and reinstated a 60 percent rating for asthma and COPD, effective March 1, 2024.

The Board granted an earlier effective date of April 21, 2021, for service connection for asthma.

The Veteran's claim for an earlier effective date of December 27, 2021, and no earlier, for the award of service connection for unspecified dermatitis was granted. The initial rating in excess of 10 percent for unspecified dermatitis was denied.

The Board granted service connection for hypertension, coronary artery disease, asthma, transient ischemic attack, neurocognitive disorder (dementia), and acquired psychiatric disorder (other specified depressive disorder) but denied service connection for renal toxicity. Several issues were remanded.

The Veteran's asthma was granted a 100 percent disability rating effective May 31, 2023, and special monthly compensation (SMC) at the housebound rate under 38 U.S.C. § 1114(s) was granted effective November 27, 2023.

The Board granted an increased rating of 60 percent for bronchial asthma, as the Veteran's symptoms met the criteria for a higher rating.

The Board remands the claims for service connection for asthma, bilateral hearing loss, curvature of the spine, and thyroid condition/nodules to correct duty to assist errors.